Acorda Therapeutics, Inc. (ACORQ)
Aug 22, 2024 - ACORQ was delisted (reason: shares cancelled)
0.0100
0.00 (0.00%)
Inactive · Last trade price
on Aug 23, 2024
Acorda Therapeutics Employees
Acorda Therapeutics had 102 employees as of December 31, 2023. The number of employees decreased by 9 or -8.11% compared to the previous year.
Employees
102
Change (1Y)
-9
Growth (1Y)
-8.11%
Revenue / Employee
$1,133,961
Profits / Employee
-$2,582,598
Market Cap
12.42K
Employees Chart
ACORQ News
- 5 months ago - Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics - Business Wire
- 8 months ago - Acorda Therapeutics Announces Delisting from Nasdaq - Business Wire
- 9 months ago - Acorda Therapeutics Announces Nasdaq Delisting Notification - Business Wire
- 9 months ago - Acorda Therapeutics shares sink nearly 40% after bankruptcy filing - Market Watch
- 9 months ago - Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement - Business Wire
- 9 months ago - Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024 - Business Wire
- 9 months ago - Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024 - Business Wire
- 1 year ago - Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 - Business Wire